Ignoring the nonsense: a phase II trial in cystic fibrosis.
Hyde
Stephen C
SC
UK Cystic Fibrosis Gene Therapy Consortium & Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford OX3 9DU, UK. steve.hyde@ndcls.ox.ac.uk
Gill
Deborah R
DR
D017322:Clinical Trials, Phase II as Topic; D018389:Codon, Nonsense / Q000037:antagonists & inhibitors*; D018388:Codon, Terminator / Q000187:drug effects; D003550:Cystic Fibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D006801:Humans; D010069:Oxadiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D011859:Radiography
D018389:Codon, Nonsense; D018388:Codon, Terminator; D010069:Oxadiazoles; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C515878:ataluren